Analgesic Activity of Hexaazaisowurtzitane Derivatives


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,03, 11,05, 9] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.

作者简介

S. Krylova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

编辑信件的主要联系方式.
Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

T. Povet’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

E. Zueva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

N. Suslov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

E. Amosova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

T. Razina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

K. Lopatina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

O. Rybalkina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

Yu. Nesterova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

O. Afanas’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

E. Kiseleva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk

S. Sysolyatin

Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences

Email: krylova5935@gmail.com
俄罗斯联邦, Biysk

D. Kulagina

Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences

Email: krylova5935@gmail.com
俄罗斯联邦, Biysk

V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: krylova5935@gmail.com
俄罗斯联邦, Tomsk


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2019
##common.cookie##